Suppr超能文献

在按绩效付费和电子质量措施时代提高脓毒症治疗效果:IDSA/ACEP/PIDS/SHEA/SHM/SIDP 联合立场文件。

Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper.

机构信息

Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.

Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.

出版信息

Clin Infect Dis. 2024 Mar 20;78(3):505-513. doi: 10.1093/cid/ciad447.

Abstract

The Centers for Medicare & Medicaid Services (CMS) introduced the Severe Sepsis/Septic Shock Management Bundle (SEP-1) as a pay-for-reporting measure in 2015 and is now planning to make it a pay-for-performance measure by incorporating it into the Hospital Value-Based Purchasing Program. This joint IDSA/ACEP/PIDS/SHEA/SHM/SIPD position paper highlights concerns with this change. Multiple studies indicate that SEP-1 implementation was associated with increased broad-spectrum antibiotic use, lactate measurements, and aggressive fluid resuscitation for patients with suspected sepsis but not with decreased mortality rates. Increased focus on SEP-1 risks further diverting attention and resources from more effective measures and comprehensive sepsis care. We recommend retiring SEP-1 rather than using it in a payment model and shifting instead to new sepsis metrics that focus on patient outcomes. CMS is developing a community-onset sepsis 30-day mortality electronic clinical quality measure (eCQM) that is an important step in this direction. The eCQM preliminarily identifies sepsis using systemic inflammatory response syndrome (SIRS) criteria, antibiotic administrations or diagnosis codes for infection or sepsis, and clinical indicators of acute organ dysfunction. We support the eCQM but recommend removing SIRS criteria and diagnosis codes to streamline implementation, decrease variability between hospitals, maintain vigilance for patients with sepsis but without SIRS, and avoid promoting antibiotic use in uninfected patients with SIRS. We further advocate for CMS to harmonize the eCQM with the Centers for Disease Control and Prevention's (CDC) Adult Sepsis Event surveillance metric to promote unity in federal measures, decrease reporting burden for hospitals, and facilitate shared prevention initiatives. These steps will result in a more robust measure that will encourage hospitals to pay more attention to the full breadth of sepsis care, stimulate new innovations in diagnosis and treatment, and ultimately bring us closer to our shared goal of improving outcomes for patients.

摘要

医疗保险和医疗补助服务中心(CMS)于 2015 年推出了严重脓毒症/感染性休克管理捆绑包(SEP-1),作为一种报告付费措施,并计划将其纳入医院价值购买计划,作为一种绩效付费措施。这份由 IDSA/ACEP/PIDS/SHEA/SHM/SIPD 联合发布的立场文件强调了对这一变化的担忧。多项研究表明,SEP-1 的实施与广谱抗生素使用、乳酸测量和疑似脓毒症患者的积极液体复苏增加有关,但与死亡率降低无关。对 SEP-1 的过分关注可能会进一步分散人们对更有效措施和全面脓毒症护理的注意力和资源。我们建议放弃 SEP-1,而不是在支付模式中使用它,转而采用新的以患者结局为重点的脓毒症指标。CMS 正在开发一种社区获得性脓毒症 30 天死亡率电子临床质量指标(eCQM),这是朝这个方向迈出的重要一步。eCQM 初步使用全身炎症反应综合征(SIRS)标准、抗生素使用或感染或脓毒症的诊断代码以及急性器官功能障碍的临床指标来识别脓毒症。我们支持 eCQM,但建议删除 SIRS 标准和诊断代码,以简化实施,减少医院之间的差异,保持对无 SIRS 的脓毒症患者的警惕,并避免在无 SIRS 的感染患者中促进抗生素的使用。我们进一步主张 CMS 使 eCQM 与疾病控制与预防中心(CDC)的成人脓毒症事件监测指标相协调,以促进联邦措施的统一,减少医院的报告负担,并促进共同的预防举措。这些步骤将产生一个更强大的指标,将鼓励医院更加关注脓毒症护理的全部范围,刺激诊断和治疗的新创新,并最终使我们更接近我们共同的改善患者结局的目标。

相似文献

引用本文的文献

6
Complex Sepsis Presentations, SEP-1 Compliance, and Outcomes.复杂脓毒症表现、SEP-1依从性及预后
JAMA Netw Open. 2025 Mar 3;8(3):e251100. doi: 10.1001/jamanetworkopen.2025.1100.

本文引用的文献

2
The Volume and Cost of Quality Metric Reporting.质量指标报告的数量和成本。
JAMA. 2023 Jun 6;329(21):1840-1847. doi: 10.1001/jama.2023.7271.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验